Intratumoral microdistribution of [131I]MB-1 in patients with B-cell lymphoma following radioimmunotherapy

Nuclear Medicine and Biology

Volumn 24, Issue 7, 1997, Pages 657-663

  Brown, Raya S ^a   Kaminski, Mark S ^b   Fisher, Susan J ^a   Chang, Alfred E ^b   Wahl, Richard L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Autoradiography; Human; Lymphoma; Monoclonal antibodies; Pan B cell; Radioimmunotherapy

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY I 131; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ANTIBODY LABELING; ARTICLE; AUTORADIOGRAPHY; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; INTRATUMORAL DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPH NODE BIOPSY; PHASE 1 CLINICAL TRIAL; RADIATION DOSE DISTRIBUTION; RADIOIMMUNOTHERAPY; TUMOR REGRESSION; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METABOLISM; METHODOLOGY; PATHOLOGY; SCINTISCANNING; SILVER STAINING;

ANTIBODIES, MONOCLONAL; AUTORADIOGRAPHY; CLINICAL TRIALS, PHASE I; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; ISOTOPE LABELING; LYMPH NODES; LYMPHOMA, B-CELL; RADIOIMMUNOTHERAPY; SILVER STAINING;

EID: 0030608982     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00099-1     Document Type: Article

References (48)

1. Badger C. C. and Fisher D. R. (1994) The importance of accurate radiation dosimetry in radioimmunotherapy of cancer [editorial; comment]. J. Nucl. Med. 35, 300-302.
2. Baxter L. T. and Jain R. K. (1990) Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics. Microvasc. Res. 40, 246-263.
3. Baxter L. T., Zhu H., Mackensen D. G. and Jain R. K. (1994) Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 54, 1517-1528.
4. Bernstein I. D., Eary J. F., Badger C. C., Press O. W., Appelbaum F. R., Martin P. J. et al. (1990) High dose radiolabeled antibody therapy of lymphoma. Cancer Res. 50(suppl), 1017s-1021s.
5. Blumenthal R. D., Fand I., Sharkey R. M., Boerman O. C., Kashi R. and Goldenberg D. M. (1991) The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. Cancer Immunol. Immunother. 33, 351-358.
6. Boxer G. M., Begent R. H., Kelly A. M., Southall P. J., Blair S. B., Theodorou N. A. et al. (1992) Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma implications for radioimmunotherapy. Br. J. Cancer 65, 825-831.
7. Brown R. S., Fisher S. J. and Wahl R. L. (1993) Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J. Nucl. Med. 34, 75-82.
8. Cobb L. M., Butler S. and Humpheys J. (1989) Distribution of injected monoclonal antibody in lymphoma-infiltrated spleen. Leuk. Res. 13, 763-769.
9. 131I Lym-1 monoclonal antibodies. Int. J. Cancer. Suppl. 3, 96-101.
10. DeNardo S. J., DeNardo G. L., O'Grady L. F., Levy N. B., Mills S. L., Macey D. J. et al. (1988) Pilot studies of radioimmunotherapy of B cell lymphoma and leukemia using I-131 Lym-1 monoclonal antibody. Antibod. Immunoconjug. Radiopharm. 1, 17-33.
11. Dvorak H. F., Nagy J. A., Dvorak J. T. and Dvorak A. M. (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133, 95-109.
12. Fidler I. J., Gersten D. M. and Hart I. R. (1978) The biology of cancer invasion and metastasis. Adv. Cancer Res. 28, 149-250.
13. Fisher D. R., Badger C. C., Breitz H., Eary J. F., Durham J. S., Hui E. et al. (1991) Internal radiation dosimetry of clinical testing of radiolabeled monoclonal antibodies. Antibody Immunoconj. Radiopharm. 4, 655-664.
14. Fraker P. J. and Speck J. Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
15. Garcia C. F., Lowder J., Meeker T. C., Bindl J., Levy R. and Warnke R. A. (1985) Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: Correlation with treatment response. J. Immunol. 135, 4252-4260.
16. Goldenberg D. M., Horowitz J. A., Sharkey R. M., Hall T. C., Murthy S., Goldenberg H. et al. (1991) Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody [see comments]. J. Clin. Oncol. 9, 548-564.
17. Griffith M. H., Yorke E. D., Wessels B. W., DeNardo G. L. and Neacy W. P. (1988) Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J. Nucl. Med. 29, 1795-1809.
18. 111In-labeled antibodies. Int. J. Radiol. Appl. Instrum. 16, 839-845.
19. Hosono M., Endo K., Hosono M. N., Kobayashi H., Shirato M., Sakahara H. et al. (1994) Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue [see comments]. J. Nucl. Med. 35, 296-300.
20. Hu S. M., Raine L. and Fanger H. (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Pathol. 75, 816-821.
21. 131I-labeled antibodies in follicular lymphoma. Med. Phys. 19, 97-104.
22. Jain R. K. (1987) Transport of molecules in the tumor interstitium: A review. Cancer Res. 47, 3039-3051.
23. Jain R. K. and Baxter L. T. (1988) Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 48, 7022-7032.
24. Jones P. L., Gallagher B. M. and Sands H. (1986) Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts. Cancer Immunol. Immunother. 22, 139-143.
25. Jonsson B. A., Strand S. E. and Larsson B. S. (1992) A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues [see comments]. J. Nucl. Med. 33, 1825-1833.
26. Jurcic J. G., Caron P. C. and Scheinberg D. A. (1995) Monoclonal antibody therapy of leukemia and lymphoma. Adv. Pharmacol. 33, 287-314.
27. Jurcic J. G. and Scheinberg D. A. (1994) Recent developments in the radioimmunotherapy of cancer. Curr. Opin. Immunol. 6, 715-721.
28. Juweid M., Neumann R., Paik C., Perez-Bacete M. J., Sato J., van Osdol W. and Weinstein J. N. (1992) Micropharmacology of monoclonal antibodies in solid tumors: Direct experimental evidence for a binding site barrier. Cancer Res. 52, 5144-5153.
29. Kaminski M. S., Fig L. M., Zasadny K. R., Koral K. F., DelRosario R. B., Francis I. R. et al. (1992) Imaging, dosimetry, and radioimmunotherapy with iodine-131-labeled anti-CD37 antibody in B-cell lymphoma. J. Clin. Oncol. 10, 1696-1711.
30. 131I]anti-B1 (anti-CD20) antibody. N. Engl. J. Med. 329, 459-465.
31. Koral K. F., Kwok C. S., Yang F. E., Brown R. S., Sisson J. C. and Wahl R. L. (1993) Autoradiography-based, three-dimensional calculation of dose rate for murine, human-tumor xenografts. Nucl. Med. Biol. 20, 901-909.
32. Kuzel T. M. and Rosen S. T. (1993) Radioimmunotherapy of lymphoma. Cancer Treat. Res. 68, 1-12.
33. Langmuir V. K., Fowler J. F., Knox S. J., Wessels B. W., Sutherland R. M. and Wong J. Y. (1993) Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. Med. Phys. 20, 601-610.
34. Lindmo T., Boven E., Cuttitta F., Fedorko J. and Bunn P. Jr. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72, 77-89.
35. Link M. P., Bindl J., Meeker T. C., Carswell C., Doss C. A., Warnke R. A. and Levy R. (1986) A unique antigen on mature B cells defined by a monoclonal antibody. J. Immunol. 137, 3013-3018.
36. Muthuswamy M. S., Roberson P. L., Ten Haken R. K. and Buchbaum D. J. (1996) A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography. Int. J. Radiat. Oncol. Biol. Phys. 35, 165-172.
37. Press O. W., Eary J. F., Badger C. C., Martin P. J., Appelbaum F. R., Levy R. et al. (1989) Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J. Clin. Oncol. 7, 1027-1038.
38. Press O. W., Farr A. G., Borroz K. I., Anderson S. K. and Martin P. J. (1989) Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res. 49, 4906-4912.
39. Press O. W., Eary J., Appelbaum F. R., Badger C. C. and Bernstein I. D. (1993) Radiolabeled antibody therapy of lymphoma. Cancer Treat. Res. 66, 127-145.
40. Press O. W., Appelbaum F. R., Eary J. F. and Bernstein I. D. (1995) Radiolabeled antibody therapy of lymphomas. Important Adv. Oncol. (Edited by DeVita VT, Hellman S and Rosenberg SA), Lippincott Company, Philadelphia, 157-171.
41. 131I-labeled monoclonal antibody: An Illinois Cancer Council Study. J. Clin. Oncol. 5, 562-573.
42. Sautter-Bihl M. L. and Bihl H. (1994) Radioimmunotherapy with monoclonal antibodies: A new horizon in nuclear medicine therapy? Nuklearmedizin 33, 167-173.
43. Schmid U., Bihl H. and Matzku S. (1990) Antibody accumulation in small tissue samples: assessment by quantitative auto radiography. Int. J. Radiol. Appl. Instrum. 17, 585-596.
44. Wahl R. L., Barrett J., Geatti O., Liebert M., Wilson B. S., Fisher S. and Wagner J. G. (1988) The intraperitoneal delivery of radiolabeled monoclonal antibodies: Studies on the regional delivery advantage. Cancer Immunol. Immunother. 26, 187-201.
45. Wahl R. L., Wissing J., del Rosario R. and Zasadny K. R. (1990) Inhibition of autoradiolysis of radiolabeled monoclonal antibodies by cryopreservation. J. Nucl. Med. 31, 84-89.
46. Weinstein J. N. and van Osdol W. (1992) Early intervention in cancer using monoclonal antibodies and other biological ligands: Micropharmacology and the "binding site barrier." Cancer Res. 52, 2747s-2751s.
47. Wilson B. S., Imai K., Natali P. G. and Ferrone S. (1981) Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int. J. Cancer 28, 293-300.
48. Yang F. E., Brown R. S., Koral K. F., Clavo A. C., Jackson G. A. and Wahl R. L. (1992) Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts. Cancer Immunol. Immunother. 35, 365-372.